0
We're unable to sign you in at this time. Please try again in a few minutes.
Retry
We were able to sign you in, but your subscription(s) could not be found. Please try again in a few minutes.
Retry
There may be a problem with your account. Please contact the AMA Service Center to resolve this issue.
Contact the AMA Service Center:
Telephone: 1 (800) 262-2350 or 1 (312) 670-7827  *   Email: subscriptions@jamanetwork.com
Error Message ......

Journal Articles

in Adverse Drug Effects
 41-60 of 756 Articles
JAMA Oncology | 
Brief Report |  ONLINE FIRST
Kenar D. Jhaveri, MD; Vipulbhai Sakhiya, MBBS; Steven Fishbane, MD
JAMA Oncol. Published online June 25, 2015. doi:10.1001/jamaoncol.2015.1713

JAMA Internal Medicine | 
Perspective |  ONLINE FIRST
Renu Mansukhani, MD
JAMA Intern Med. Published online June 22, 2015. doi:10.1001/jamainternmed.2015.2708

JAMA Ophthalmology | 
Original Investigation |  FREE ONLINE FIRST
Ahmad A. Aref, MD; Ingrid U. Scott, MD, MPH; Neal L. Oden, PhD; et al.
JAMA Ophthalmol. Published online June 18, 2015. doi:10.1001/jamaophthalmol.2015.1823
Includes: Supplemental Content

JAMA Dermatology | 
Observation |  ONLINE FIRST
Ryan Gillihan, BS; Tony Nguyen, MD; Ryan Fischer, MD; et al.
JAMA Dermatol. Published online June 17, 2015. doi:10.1001/jamadermatol.2015.1252

JAMA Ophthalmology | 
Observation |  ONLINE FIRST
Molly L. Fuller, MD, PhD; Elizabeth A. Bradley, MD
JAMA Ophthalmol. Published online June 04, 2015. doi:10.1001/jamaophthalmol.2015.1666

JAMA Internal Medicine | 
Teachable Moment | 
Bharat Kumar, MD; Melissa L. Swee, MD, MS
JAMA Intern Med. 2015;175(6):892-893. doi:10.1001/jamainternmed.2015.0809.

JAMA Internal Medicine | 
Research Letter | 
Waqas T. Qureshi, MD; Wesley T. O’Neal, MD, MPH; Yulia Khodneva, MD, PhD; et al.
JAMA Intern Med. 2015;175(6):1058-1060. doi:10.1001/jamainternmed.2015.1045.

JAMA Dermatology | 
Editorial | 
Thomas J. Moore, AB
JAMA Dermatol. 2015;151(6):585-586. doi:10.1001/jamadermatol.2015.37.

JAMA Dermatology | 
Original Investigation | 
Steven M. Belknap, MD; Imran Aslam, BS; Tina Kiguradze, BS; et al.
JAMA Dermatol. 2015;151(6):600-606. doi:10.1001/jamadermatol.2015.36.

JAMA Ophthalmology | 
Original Investigation | 
Bethany Stavert, BSc; Myra B. McGuinness, MSc; C. Alex Harper, MBBS; et al.
JAMA Ophthalmol. 2015;133(6):647-652. doi:10.1001/jamaophthalmol.2015.0325.
Includes: Supplemental Content

JAMA Oncology | 
From The JAMA Network |  FREE ONLINE FIRST
Stacey L. Berg, MD; D. Williams Parsons, MD, PhD
JAMA Oncol. Published online May 28, 2015. doi:10.1001/jamaoncol.2015.1173

JAMA Dermatology | 
Original Investigation |  ONLINE FIRST
Robert E. Kalb, MD; David F. Fiorentino, MD, PhD; Mark G. Lebwohl, MD; et al.
JAMA Dermatol. Published online May 13, 2015. doi:10.1001/jamadermatol.2015.0718
Includes: Supplemental Content

JAMA Neurology | 
Research Letter | 
Brendan A. I. Payne, PhD, FRCPath; Kristian Gardner, MSc; Emma L. Blakely, PhD; et al.
JAMA Neurol. 2015;72(5):603-605. doi:10.1001/jamaneurol.2015.0150.

JAMA Oncology | 
Viewpoint |  FREE
Leonard B. Saltz, MD
JAMA Oncol. 2015;1(2):141-142. doi:10.1001/jamaoncol.2015.0287.

JAMA Pediatrics | 
Editorial | 
Richard I. G. Holt, PhD, FRCP
JAMA Pediatr. 2015;169(5):427-428. doi:10.1001/jamapediatrics.2015.144.

JAMA Pediatrics | 
Original Investigation | 
Wendy Camelo Castillo, PhD; Kim Boggess, MD; Til Stürmer, PhD; et al.
JAMA Pediatr. 2015;169(5):452-458. doi:10.1001/jamapediatrics.2015.74.
Includes: Supplemental Content

JAMA Dermatology | 
Case Report/Case Series | 
Cristina Carrera, MD, PhD; Joan A. Puig-Butillè, PhD; Gemma Tell-Marti, Ph; et al.
JAMA Dermatol. 2015;151(5):544-548. doi:10.1001/jamadermatol.2014.4115.

JAMA Ophthalmology | 
Original Investigation | 
Anjali Parekh, MD; Sunil Srivastava, MD; James Bena, MS; et al.
JAMA Ophthalmol. 2015;133(5):568-573. doi:10.1001/jamaophthalmol.2015.51.
Includes: Supplemental Content

JAMA Ophthalmology | 
Original Investigation | 
Susan B. Bressler, MD; Talat Almukhtar, MBChB; Anjali Bhorade, MD; et al.
JAMA Ophthalmol. 2015;133(5):589-597. doi:10.1001/jamaophthalmol.2015.186.

JAMA Ophthalmology | 
Original Investigation | 
Jessica A. Olayanju, BS; Mohamed B. Hassan, BA; David O. Hodge, MS; et al.
JAMA Ophthalmol. 2015;133(5):574-580. doi:10.1001/jamaophthalmol.2015.57.
Includes: Supplemental Content

Sign in

Purchase Options

• Subscribe to the journal
• Rent this article ?

A free personal account provides

• Free current issues on The JAMA Network Reader
• Free quizzes on The JAMA Network Challenge
• Commenting and personalized alerts
From The JAMA Network
JAMA Otolaryngology–Head & Neck Surgery
Original Investigation  | 
Prediction of Hearing Loss Due to Cisplatin Chemoradiotherapy
Eleonoor A. R. Theunissen, MD; Charlotte L. Zuur, MD, PhD; Katarzyna Jóźwiak, PhD; et al.
JAMA Ophthalmology
Original Investigation  | 
Association of Compounded Bevacizumab With Postinjection Endophthalmitis
Brian L. VanderBeek, MD, MPH; Sarah G. Bonaffini, BS; Liyuan Ma, MS
JAMA Oncology
From The JAMA Network  | 
Prognostic Significance of Cutaneous Adverse Events Associated With Pembrolizumab Therapy
Jennifer A. Lo, BA; David E. Fisher, MD, PhD; Keith T. Flaherty, MD
JAMA Oncology
Invited Commentary  | 
PROceeding With the Patient-Reported Outcomes (PROs) Version of the Common Terminology Criteria for Adverse Events
Benjamin Movsas, MD